SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner

Sci Rep. 2023 Dec 18;13(1):22877. doi: 10.1038/s41598-023-49961-x.

Abstract

Transforming growth factor β (TGF-β) is a multifunctional cytokine that induces a diverse set of cellular processes principally through Smad-dependent transcription. Transcriptional responses induced by Smads are tightly regulated by Smad cofactors and histone modifications; however, the underlying mechanisms have not yet been elucidated in detail. We herein report lysine methyltransferase SET8 as a negative regulator of TGF-β signaling. SET8 physically associates with Smad2/3 and negatively affects transcriptional activation by TGF-β in a catalytic activity-independent manner. The depletion of SET8 results in an increase in TGF-β-induced plasminogen activator inhibitor-1 (PAI-1) and p21 expression and enhances the antiproliferative effects of TGF-β. Mechanistically, SET8 occupies the PAI-1 and p21 promoters, and a treatment with TGF-β triggers the replacement of the suppressive binding of SET8 with p300 on these promoters, possibly to promote gene transcription. Collectively, the present results reveal a novel role for SET8 in the negative regulation of TGF-β signaling.

MeSH terms

  • Methylation
  • Plasminogen Activator Inhibitor 1* / genetics
  • Plasminogen Activator Inhibitor 1* / metabolism
  • Signal Transduction / physiology
  • Smad2 Protein / genetics
  • Smad2 Protein / metabolism
  • Transcriptional Activation
  • Transforming Growth Factor beta* / metabolism

Substances

  • Transforming Growth Factor beta
  • Plasminogen Activator Inhibitor 1
  • Smad2 Protein